Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 2.4. It has been cited 89 times, with 66 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.675
From this paper's citation signal
Citation Network Contribution
1.8
From 46 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 66 citers.
Amgen
Medtronic
Bristol-Myers Squibb
European Commission
Merck
Patient-Centered Outcomes Research Institute
Sanofi Pasteur
Boehringer Ingelheim
Cytokinetics
LivaNova
Sanofi
Gilead Sciences
Novartis
AstraZeneca
MyoKardia
National Heart, Lung, and Blood Institute
National Institutes of Health
American Heart Association
Bayer Fund
GlaxoSmithKline
Roche
Sphingotec GmbH
MeSH Terms
Keywords